Position in MRK
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$3,179,604
+$327,649 QoQ
Shares Held
24,744
+4.4% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.28%
of 13F equity value
Holder Rank
#1,303
of 3,769 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 5%
Shared 0%
None 95%
Common Shares in MRK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026HOWE & RUSLING INC holds $48,551,537 across 10 Drug Manufacturers - General names. MRK ranks #4 (6.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
97,901 | $24,635,807 | |
| 2 | AZN |
Astrazeneca PLC
|
42,193 | $8,000,635 | |
| 3 | JNJ |
Johnson & Johnson
|
29,374 | $7,460,114 | |
| 4 | MRK |
Merck & Co., Inc.
This page
|
24,744 | $3,179,604 | |
| 5 | AMGN |
Amgen Inc
|
4,998 | $1,809,875 | |
| 6 | LLY |
ELI LILLY & Co
|
1,076 | $1,290,586 | |
| 7 | PFE |
Pfizer Inc
|
35,247 | $848,747 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
5,437 | $686,910 |
All Filings in MRK
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,179,604 | 24,744 | Shares | Sole | 2026-08-10 | |
| 2026-03-31 | $2,851,955 | 23,709 | Shares | Sole | 2026-04-28 | |
| 2025-12-31 | $2,390,349 | 22,709 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $1,632,354 | 19,449 | Shares | Sole | 2025-11-05 | |
| 2025-06-30 | $1,549,477 | 19,574 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $1,779,222 | 19,822 | Shares | Sole | 2025-06-17 | |
| 2024-12-31 | $1,896,287 | 19,062 | Shares | Sole | 2025-02-12 | |
| 2024-09-30 | $2,283,350 | 20,107 | Shares | Sole | 2024-11-08 | |
| 2024-06-30 | $2,378,693 | 19,214 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $2,491,347 | 18,881 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $2,042,707 | 18,737 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $1,884,602 | 18,306 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $2,153,408 | 18,662 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $1,946,830 | 18,299 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $1,737,366 | 15,659 | Shares | Sole | 2023-02-15 | |
| 2022-09-30 | $1,359,920 | 15,791 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $1,356,427 | 14,878 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $135,136 | 1,647 | Shares | Sole | 2022-05-10 | |
| 2021-12-31 | $142,703 | 1,862 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $174,480 | 2,323 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $564,143 | 7,254 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $3,234,775 | 41,961 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $3,366,722 | 41,158 | Shares | Sole | 2021-02-08 | |
| 2020-09-30 | $3,547,026 | 42,761 | Shares | Sole | 2020-11-06 | |
| 2020-06-30 | $12,628,458 | 163,306 | Shares | Sole | 2020-07-15 | |
| 2020-03-31 | $7,934,741 | 103,129 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||